This page is educational and not medical advice. Discuss your own results, and any treatment you are considering, with a clinician or licensed provider.
C-reactive protein is a protein the liver releases in response to inflammatory signalling, mainly interleukin-6, so the blood level acts as a general readout of how much inflammation the body is handling at the moment of the draw. The high-sensitivity version of the assay, hs-CRP, measures the low concentrations used in cardiovascular risk discussion[1]. A typical lab reference range is 0 to 3 mg/L, and FitScript's optimal range is 0 to 1 mg/L. That optimal figure is an optimization target, not a diagnostic cut-off, and standard ranges vary by lab, age and sex. Higher readings may reflect infection, recent injury, excess body fat, smoking or autoimmune activity, while low readings are generally unremarkable. The C-Reactive Protein marker page covers the test itself, the ranges and result interpretation in depth.
A raised hs-CRP matters because it tracks low-grade inflammation, a process repeatedly associated with cardiovascular events even after cholesterol is accounted for[2]. Inflammation is involved at every stage of atherosclerosis, from endothelial activation and monocyte recruitment through to plaque growth and plaque instability, which is why laboratory medicine regards hs-CRP as information that sits alongside lipids rather than duplicating them[3].
Two caveats keep this honest. First, CRP is a marker of a process, not the process itself. Nobody has shown that pushing the number down for its own sake changes outcomes, so the useful question is always what is generating the signal. Second, the marker is not specific to the heart. A persistently raised value can reflect autoimmune activity, an unresolved infection, gum disease, obesity or several of these at once, which is why one number never stands alone.
What a raised value does do well is prompt a better conversation. It flags that something inflammatory is running in the background, and it gives a measurable way to see whether the changes someone makes over the following months actually register in their biology. That is the practical value of the marker, and it is worth discussing any out-of-range result with a clinician rather than acting on it alone.
Most raised readings come from a short list of recurring drivers, and identifying which one applies is the whole job.
| Common driver | How it is thought to raise CRP | Direction of change that tends to help |
|---|---|---|
| Excess visceral fat | Adipose tissue releases interleukin-6, which signals the liver to produce more CRP | Gradual, sustained fat loss |
| Insulin resistance and high blood sugar | Metabolic stress amplifies inflammatory signalling and adipose dysfunction | Activity, fat loss, carbohydrate quality |
| Smoking and vaping | Airway and systemic oxidative stress | Stopping, with support if needed |
| Acute infection, injury or surgery | A normal acute phase response | Time, recovery, retest later |
| Autoimmune and inflammatory conditions | Ongoing immune activation | Management with a clinician |
| Periodontal (gum) disease | Chronic local infection with systemic spill-over | Dental assessment and care |
| Short, fragmented sleep or sleep apnoea | Sympathetic activation and intermittent hypoxia | Sleep assessment |
| Oral oestrogen in some contraceptives and hormone therapy | First-pass liver effect increases CRP production | Context for interpretation, discussed with the prescriber |
Pregnancy, recent vaccination and an unusually hard training session can all lift the value temporarily too. None of these is a reason to panic, and none is a reason to ignore the result either. They are reasons to know what was happening in the days before the blood was drawn.
Usually not much, because CRP is a moving target by design. The protein rises within hours of an inflammatory stimulus and falls once that stimulus clears, so a single elevated reading taken during a cold, a flare of back pain or the week after a dental procedure says more about that week than about long-term inflammatory burden.
When hs-CRP is used to characterise background inflammation, the standard approach is more than one measurement taken when the person is well, rather than a single snapshot[1]. Values in the higher range, particularly those well above the usual reference ceiling, more often reflect an acute process and are generally repeated after recovery before anyone draws conclusions.
The useful mental model is observation, then meaning, then next step. The observation is a number. The meaning is a hypothesis about what might be generating it. The next step is a repeat test under clean conditions, and a conversation about the result.
Fat loss is the single best-supported lever. Reviews of weight-loss studies have found that reductions in body weight are associated with meaningful reductions in CRP, with larger losses generally tracking larger falls in the marker[4]. The mechanism is direct rather than mysterious. Visceral and subcutaneous adipose tissue secrete interleukin-6, interleukin-6 instructs the liver to synthesise CRP, and less adipose tissue means less of that signal.
Intensive lifestyle intervention has been studied formally in this context. In an analysis from the Look AHEAD trial, a lifestyle intervention in people with type 2 diabetes was associated with reductions in CRP, and the effect of combining lifestyle change with lipid-lowering medication was studied alongside it[5].
Two practical points follow. Waist circumference is often the more informative companion measure, because visceral fat is the more inflammatory compartment and someone can lose it while the scale moves slowly. And the rate matters less than the retention. Very rapid loss followed by regain tends to land people back where they started, biologically as well as on the scale, so the aim is a deficit that can be held for months without wrecking sleep, training or appetite.
Whole-food patterns rich in fibre, vegetables, legumes, nuts and oily fish are the ones most consistently associated with lower hs-CRP, and no single food carries the effect. In a randomised controlled trial in women with polycystic ovary syndrome, a DASH-style eating pattern was associated with improvements in insulin resistance and reductions in hs-CRP compared with a control diet[6]. That pairing is informative, because it suggests much of the inflammatory benefit of diet runs through metabolic improvement rather than through any direct anti-inflammatory property of the food.
Fat quality appears to contribute as well. An intervention study of increased alpha-linolenic acid intake, the plant omega-3 found in walnuts, flaxseed and rapeseed oil, reported lower C-reactive protein, though the same study found no effect on markers of atherosclerosis[7]. That is a useful illustration of the gap between moving a marker and changing a disease process.
In practice, the changes with the most leverage tend to be unglamorous. More fibre from a wide range of plants, which supports the gut barrier and glycaemic control. Oily fish or another credible omega-3 source a couple of times a week. Fewer highly refined carbohydrates and ultra-processed foods, which drive the postprandial glucose and insulin excursions associated with inflammatory signalling. Less alcohol. Enough protein and enough total energy to protect muscle while losing fat, since crash dieting that strips lean mass rarely holds.
Nothing here requires an elimination diet. The pattern is the intervention.
Regular aerobic exercise is associated with lower hs-CRP, and the effect builds over weeks rather than sessions. In a study of people with obesity and impaired glucose tolerance, twelve weeks of moderate aerobic exercise was associated with reductions in hs-CRP alongside changes in glycaemic measures[8]. Moderate is the operative word. That means the sort of effort that allows broken conversation, sustained for thirty to forty-five minutes.
The mechanisms overlap with everything else on this page. Training reduces visceral fat, improves insulin sensitivity, improves sleep quality and changes the signalling environment of skeletal muscle in ways that may favour a less inflammatory state over time.
One quirk catches people out. A single hard or unaccustomed session, a long run, a heavy lifting day, a first race, raises CRP acutely as part of normal tissue repair. A test taken two days after a punishing workout can look alarming and mean nothing beyond muscle damage. Leave a few easy days before blood work if a clean reading matters.
Resistance training deserves a place too. It is not usually the headline intervention for this marker, but it protects lean mass during fat loss and improves glucose disposal, both of which support the drivers that matter here.
Yes, this is one of the clearer signals in the literature. A review of C-reactive protein in smokers and former smokers found that CRP concentrations are higher in current smokers, and that former smokers sit between current smokers and people who have never smoked[9]. The pattern suggests part of the elevation resolves after quitting while some residue may persist for a long time.
Mechanistically this is straightforward. Inhaled smoke produces chronic airway irritation and systemic oxidative stress, both of which sustain inflammatory signalling. Vaping is less well characterised for this specific marker, and it is too early to call it inert.
For anyone with a raised hs-CRP who smokes, this is almost always the highest-yield change available, and it is worth asking a clinician what cessation support is appropriate, since behavioural support and prescription options exist and a licensed provider evaluates whether any medication fits the individual.
All three plausibly influence the marker, and sleep is the one most often missed. Short sleep and fragmented sleep are associated with higher inflammatory markers, and obstructive sleep apnoea adds intermittent hypoxia and repeated sympathetic surges on top of that. A persistently raised hs-CRP in someone who snores heavily, wakes unrefreshed or has a thick neck circumference is a reasonable prompt to ask a clinician about a sleep assessment.
Alcohol is dose-dependent and individual. Heavy intake burdens the liver and the gut barrier, and reducing it frequently improves sleep quality, body composition and glycaemic control at the same time, which makes isolating a single mechanism difficult and largely beside the point.
Psychological stress is harder to measure but not irrelevant. Sustained stress affects cortisol rhythm, sleep, appetite and alcohol use, and chronic stress is associated with higher inflammatory signalling. The practical interventions, regular sleep timing, daylight exposure in the morning, aerobic activity, some form of downshift in the evening, are the same ones that help the other drivers.
One more overlooked contributor is oral health. Chronic gum inflammation is a genuine source of systemic inflammatory signal, and a dental check-up is a cheap thing to rule in or out.
Some have supportive data, most do not, and none of them substitute for the drivers above. Omega-3 intake is the most studied. Increased alpha-linolenic acid intake was associated with lower C-reactive protein in intervention work, without accompanying change in atherosclerosis markers[7].
Micronutrient status appears to matter in specific populations rather than universally. A randomised study of zinc, vitamin A and magnesium co-supplementation in people with hypothyroidism reported effects on thyroid function, oxidative stress and hs-CRP[10]. That is a finding in a defined group with a defined condition, not a general recommendation, and it illustrates why correcting a measured deficiency is a different proposition from supplementing blindly.
Red yeast rice sits in a category of its own. Research in moderately hypercholesterolaemic adults found improvements in lipid pattern, hs-CRP and vascular remodelling parameters[11]. It contains a compound that acts like a prescription cholesterol medicine, so product strength varies between brands and it can interact with prescription medicines. It belongs in a conversation with a clinician rather than in a basket next to the multivitamin.
Curcumin, vitamin D and various polyphenol extracts are commonly promoted for this marker. Whether they help is uncertain, the formulations used have been inconsistent and the courses short, so any effect is likely modest at best. Detox protocols, cleanses and anti-inflammatory supplement stacks have no credible basis for lowering background inflammation. Any supplement is also worth mentioning to a prescriber, because interactions are real.
Several prescription medicines are associated with lower hs-CRP, and in every case a licensed provider evaluates whether one is appropriate for the individual.
Cholesterol-lowering medicines are the longest-standing example. Beyond their effect on LDL, they are associated with reductions in C-reactive protein, and this dual effect has been examined directly against and alongside lifestyle intervention[5]. Laboratory medicine references discuss hs-CRP alongside lipoprotein measurement precisely because the two carry partly separate information about atherosclerotic risk[3].
A prespecified secondary analysis of the SELECT trial examined the effect of semaglutide on hs-CRP in people with established cardiovascular disease and overweight or obesity, reporting reductions in the inflammatory biomarker[12]. How much of that reflects weight change and how much reflects other mechanisms is still being worked out, and these medicines carry side effects and eligibility criteria that only a prescriber can weigh.
Targeted anti-inflammatory therapy in cardiology is still developing, and it remains clinician-gated and specialist-led. No doses, schedules or administration details belong in an article, including this one. The useful takeaway is that medication is one branch of a decision tree that starts with why the marker is raised, and that branch is navigated with a licensed provider who has seen the full clinical picture.
CRP itself turns over quickly, within roughly a day, so the blood level responds to changes in signalling within days rather than months. What takes time is the signal, not the protein. An elevation caused by a chest infection often resolves within weeks of recovery. An elevation driven by adiposity, insulin resistance or smoking moves on the timescale of the underlying change.
As a planning assumption, the intervention studies that report reductions in hs-CRP typically run for around twelve weeks or longer[8]. That is a reasonable interval to expect something measurable from consistent training, dietary change or fat loss, and it is also long enough that a single weekend of indiscipline will not show up.
Expect noise. Repeat hs-CRP measurements in the same person vary from week to week even without any intervention, so a small movement in either direction should not be over-read. The trend across several tests taken under similar conditions carries far more information than the gap between any two readings, and no honest article can promise a specific drop for a specific person.
Retest when well, under conditions as close as possible to the previous test. That means no acute illness, no recent vaccination, no surgery or dental work in the preceding weeks, no hard or unaccustomed training in the two or three days before, and ideally the same time of day. The high-sensitivity assay is the one to request when the question is background inflammation rather than acute illness.
One test is a data point. Two or three tests spread over months, read against body composition, blood pressure, glucose markers and lipids, are a trend, and a trend is what justifies changing anything. Keeping a brief note of context next to each result, recent illness, training load, sleep, alcohol, makes later interpretation far easier.
This is also where repeat panels earn their place. A membership such as FitScript's includes 150+ biomarkers tested per year, with Atlas, its AI health advisor, interpreting each result against the ones before it, and any treatment decision sitting with a licensed provider who reviews the member. Whatever the setting, the principle is the same. Compare like with like, and let a clinician interpret anything unexpected.
Inflammation rarely travels alone, so hs-CRP is most informative in company.
| Marker | What it adds next to hs-CRP |
|---|---|
| Apolipoprotein B | Counts the atherogenic particles carrying cholesterol, information lipids alone can blur |
| Fasting insulin | Surfaces insulin resistance early, often before glucose or HbA1c shift |
| HbA1c | Gives an average glycaemic picture over months |
| Homocysteine | A separate vascular-risk marker influenced by B-vitamin status and genetics |
| Fibrinogen | Another acute phase protein, and a contributor to clotting tendency |
| Ferritin | Also rises with inflammation, which is why it is read with iron studies rather than alone |
| ESR | A slower, non-specific inflammatory measure used in different clinical contexts |
| Liver enzymes | Flag fatty liver, a common companion of visceral adiposity and inflammation |
Read together, these markers usually point towards the dominant driver. A raised hs-CRP with raised fasting insulin, raised triglycerides and fatty liver enzymes tells a metabolic story. A raised hs-CRP with a normal metabolic picture and joint symptoms tells a different one, and that distinction belongs with a clinician.
Promptly means soon rather than at the next routine appointment, and a few situations qualify. A markedly elevated result, particularly one well above the standard reference ceiling, is worth discussing with a clinician promptly, because values in that territory more often reflect an active process that deserves identification. The same applies when a raised value comes with fever, unexplained weight loss, night sweats, persistent joint swelling or pain, chest pain, breathlessness or new neurological symptoms.
A result that stays suboptimal across repeated tests, despite months of genuine change in sleep, training, body composition and smoking status, is also worth escalating. Persistent low-grade elevation with no obvious explanation can reflect something that needs a clinical workup rather than another lifestyle adjustment.
Never ignore an abnormal result, and never stop or start a prescribed medicine on the strength of a biomarker read at home. Bring the numbers, the dates and the context to the appointment, and let the person with full clinical information decide what comes next.
For related markers, see Homocysteine, Fibrinogen Activity, Apolipoprotein B and Fasting Insulin. The Heart Health panel groups several of these markers together in one draw.
Address what is raising it. Levers that may help include losing excess body fat, regular moderate aerobic exercise, stopping smoking, a fibre-rich whole-food eating pattern and better sleep. Resolving infection or gum disease matters too. Some medicines lower it, and a licensed provider evaluates whether any of them are appropriate.
Work on the drivers rather than the number. Fat loss, particularly around the waist, is the most consistently supported change, followed by regular aerobic activity and smoking cessation. Improving insulin resistance through diet and movement is associated with lower hs-CRP. Retest when well, after about twelve weeks of consistent change.
Start by identifying the cause. Common drivers include excess visceral fat, insulin resistance, smoking, poor or apnoeic sleep, gum disease and ongoing infection. Changing those is what moves the marker. Supplements play a small, population-specific role, and any prescription option is decided by a licensed provider after review.
Through sustained changes to the underlying process. Weight loss, twelve or more weeks of moderate aerobic exercise, and DASH-style eating patterns that improve insulin resistance are each associated with reductions in hs-CRP. Stopping smoking is associated with lower values than continuing. Discuss persistent elevation with a clinician.
A typical lab reference range is 0 to 3 mg/L, while FitScript's optimal range is 0 to 1 mg/L. That optimal figure is an optimization target rather than a diagnostic cut-off, and standard reference ranges vary by laboratory, age and sex. Interpretation always depends on context and repeat testing.
Yes. A hard or unaccustomed session causes muscle damage and a normal repair response, which can lift CRP for a day or two. That is why a blood draw taken soon after a long run or heavy training day can look misleading. Leave a few easy days before testing.
Sometimes, though diet usually works through fat loss and improved insulin sensitivity rather than directly. A DASH-style pattern may lower hs-CRP alongside improving insulin resistance. Results vary between people, and diet is most effective combined with activity, sleep and smoking cessation.
Often enough to see a trend, not so often that noise dominates. Retesting after roughly three months of consistent change is reasonable, and the test should be taken when well, away from illness, vaccination, surgery or hard training. Compare like with like, and review results with a clinician.
No. A raised value shows inflammation somewhere in the body and is associated with cardiovascular risk at a population level, but it does not identify a condition in any individual. It may reflect infection, obesity, smoking or autoimmune activity. A clinician interprets it alongside your other markers and history.